Provided by Tiger Trade Technology Pte. Ltd.

Bristol-Myers Squibb

56.61
-0.9750-1.69%
Volume:2.53M
Turnover:143.33M
Market Cap:115.23B
PE:12.46
High:58.02
Open:57.71
Low:56.15
Close:57.58
52wk High:68.64
52wk Low:42.52
Shares:2.04B
Float Shares:2.03B
Volume Ratio:1.14
T/O Rate:0.12%
Dividend:2.51
Dividend Rate:4.43%
EPS(TTM):4.54
EPS(LYR):3.46
ROE:46.60%
ROA:10.72%
PB:5.16
PE(LYR):16.36

Loading ...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Lemaitre Vascular (LMAT) and Bristol-Myers Squibb (BMY)

TIPRANKS
·
46 mins ago

Truist Financial Sticks to Its Buy Rating for Bristol-Myers Squibb (BMY)

TIPRANKS
·
2 hours ago

Bristol-Myers Squibb Company : Wells Fargo Cuts Target Price to $60 from $65

THOMSON REUTERS
·
3 hours ago

Wells Fargo Adjusts Price Target on Bristol-Myers Squibb to $60 From $65

MT Newswires Live
·
4 hours ago

US Research Roundup-Essex Property Trust, Qualys, Vulcan Materials

Reuters
·
6 hours ago

Analysts Offer Insights on Healthcare Companies: Roivant Sciences (ROIV), Bristol-Myers Squibb (BMY) and Palvella Therapeutics (PVLA)

TIPRANKS
·
16 hours ago

Bristol Myers Squibb Co. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
17 hours ago

Nurix Therapeutics Q3 Swings to Profit on Roche Collaboration

Reuters
·
18 hours ago

Sector Update: Healthcare Stocks Rise Late Afternoon

MT Newswires Live
·
18 hours ago

Market Chatter: Bristol-Myers Squibb Says Patient Death Likely Unrelated to Admilparent Treatment

MT Newswires Live
·
20 hours ago

RBC says Bristol Myers’ ALOFT-IPF efficacy ‘encouraging, but confounding’

TIPRANKS
·
20 hours ago

Bristol Myers has blockbuster opportunity in IPF, says William Blair

TIPRANKS
·
20 hours ago

Bristol Myers tells Bloomberg admilparent death unlikely due to drug

TIPRANKS
·
20 hours ago

Analysts Have Conflicting Sentiments on These Healthcare Companies: Bristol-Myers Squibb (BMY) and AxoGen (AXGN)

TIPRANKS
·
21 hours ago

Bristol-Myers Squibb Co Stock (BMY) Moved Down by 3.35% on Oct 12: What Signal Does It Send?

TradingKey
·
22 hours ago

US Stocks on the MOVE-Microsoft, C3.ai, Salesforce, Bristol Myers

Reuters
·
22 hours ago

Bristol Myers Stock is Rising on a Double Dose of Good News

Dow Jones
·
Yesterday

Movement Alert|Bristol-Myers Squibb Falls 3.36% in Regular Trading, Profit-Taking After Two Phase 3 Wins

Market Focus
·
Yesterday

Bristol Phase 3 success with admilparant should send Contineum up, says Stifel

TIPRANKS
·
Yesterday

Bristol-Myers Squibb: Zenbexus Phase III Validates Benefit but Competitive Pressures Keep Risk/Reward Balanced at Hold

TIPRANKS
·
Yesterday